Potential for New Therapies to Treat both Diseases The discovery of a molecular mechanism linking Alzheimerās disease and Type 2 Diabetes could lead to exciting new drugs to treat both devastating diseases, according to new research published this week in The Journal of Neuroscience. Ā Researchers found that the gene for ...
September 30, 2010
Rik Ossenkoppele is an associate professor in Translational Neuroscience and PI at the Alzheimercenter Amsterdam of the Amsterdam UMC and at Lund University in Sweden. He works on the intersection between neuroimaging, biomarkers and cognition in Alzheimerās disease. His main motivation is to contribute to improving the diagnostic/prognostic work-up (short-term ...
May 11, 2022
When Gerry Nogelo of Vero Beach, Fla., turned 70 on Nov. 8, 2012, she only had one wishāto find a cure for Alzheimerās disease. So she mailed more than 40 letters to her friends and family asking them to make a donation to Cure Alzheimerās Fund in honor of her ...
December 24, 2013
Growing up in Pittsburgh, my first experience knowing someone with Alzheimerās was when my great-grandmother Mammam Miller lived with our family. Ā After dinner together, she would tell us she was ready to return home. She was in her 90ās and physically frail, but firm in her belief that the trolley ...
August 27, 2019
Join us for a great day of golf for a great cause! Cure Alzheimer’s Philadelphia is hosting a golf tournament at the beautiful and exclusive Bidermann Golf Course in Wilmington, DE on September 14. All proceeds from the event will go to Cure Alzheimer’s Fund for the support of Alzheimer’s ...
August 7, 2015
A new “alternative amyloid hypothesisā from the lab of Dr. Charles Glabe, at the University of California at Irvine, helps explain precisely how neurons (nerve cells) die in Alzheimerās disease and how known genetic mutations initiate a chain reaction in this long process. The important new hypothesis was driven by ...
August 14, 2014
I am an Assistant Professor of Neurology at Massachusetts General Hospital and Harvard Medical School. My research focus is to understand the cellular and molecular mechanisms of Alzheimerās disease (AD) pathophysiology. A key feature of Alzheimerās disease (AD) is the formation of amyloid plaques in the brain decades before symptoms ...
October 29, 2021
Founding Board Member of Cure Alzheimerās Fund Jeffrey L. Morby had an extensive and distinguished career in for-profit institutions and not-for-profit organizations. Founder of Cure Alzheimerās Fund, a public charity funding research focused on finding a cure for Alzheimerās disease. Co-Chairman, along with his wife, Jacqueline, of the Morby Family Charitable Foundation Financial Executive ...
April 27, 2017
Cure Alzheimer’s Fund is extremely happy with the House Appropriations Subcommittee bill for the National Institutes of Health (NIH) that was released today. The bill, which still has to be approved by the Committee and full House, includes a $1.1 billion increase for NIH, a more than 25% increase for the ...
June 16, 2015
2019-2022 Alzheimerās disease (AD) is the most common form of dementia, affecting approximately 50 million individuals worldwide. With prevalence expected to double every 20 years, AD is a global health crisis requiring urgent action. Unfortunately, despite years of basic and clinical research, no treatments to prevent, slow down or reverse the ...
January 5, 2017
